BiotechTube
Home/Mireca Medicines/Barbara Brunnhuber, Ir MSc
BB

Barbara Brunnhuber, Ir MSc

Chief Executive Officer

Mireca Medicines

Therapeutic Areas

OphthalmologyNeurodegenerative Diseases

Mireca Medicines Pipeline

DrugIndicationPhase
cGMP analog for neuroprotectionInherited Retinal Diseases (Retinitis Pigmentosa, Leber's Congenital Amaurosis, Stargardt's disease)Preclinical

Leadership Team at Mireca Medicines

PF
Prof. François Paquet-Durand, PhD
Scientific Founder
PJ
Pieter J. Gaillard, PhD
Chairman of the Supervisory Board
View full Mireca Medicines profile